𝛼SK or Search

ENTITY

Halozyme Therapeutics (HALO US)

28

Analysis

Health Care • United States

Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.

more

Refresh

Exchange Announcement • 01 Oct 2026 04:20

Current Report (Form 8-K | Period ending 2026-09-28)

Exchange Announcement • 23 Sep 2026 04:41

Current Report (Form 8-K | Period ending 2026-09-22)

Exchange Announcement • 18 Sep 2026 20:23

Current Report (Form 8-K | Period ending 2026-09-17)

Exchange Announcement • 17 Sep 2026 04:32

Current Report (Form 8-K | Period ending 2026-09-16)

Exchange Announcement • 19 Aug 2026 04:04

Current Report (Form 8-K | Period ending 2026-08-14)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x